Ukr.Biochem.J. 2025; Volume 97, Issue 3, May-Jun, pp. 48-54

doi: https://doi.org/10.15407/ubj97.03.048

Plasma levels of pituitary adenylate cyclase-activating polypeptide and brain-derived neurotrophic factor are not significantly altered in posttraumatic stress disorder and traumatic brain injury

A. Shcherbakova1, D. Martsenkovskyi2, D. Stroy3, A. Savchenko4,
K. Vosnitsyna5, O. Sulaieva1, O. Dudin1, V. Dosenko3

1Medical Laboratory CSD LAB;
2Department of Psychiatry, Bogomolets National Medical University, Kyiv, Ukraine;
3Bogomolets Institute of Physiology, National A cademy of Sciences of Ukraine, Kyiv;
4Scientific and Medical Center “Doslid” (LLC “Medical Research”), Kyiv, Ukraine;
5State Institution Veteran Mental Health and Rehabilitation Center Forest Glade Ministry of Health of Ukraine, Kyiv, Ukraine;
e-mail: anna82201@gmail.com

Received: 04 April 2025; Revised: 12 May 2025;
Accepted: 11 June 2025; Available on-line: 07 July 2025

Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) are common consequences of combat exposure, significantly affecting both mental and physical health of military personnel. Identifying reliable biomarkers for these conditions is critical for timely diagnosis, monitoring of treatment effectiveness, and prediction of the disease course. The results of recent studies suggesting potential role of PACAP and BDNF in peripheral blood as biomarkers for PTSD have been yet unconclusive. In this study we analyzed the level of pituitary adenylate cyclase-activating polypeptide and brain-derived neurotrophic factor in the blood plasma of 450 soldiers of the Armed Forces of Ukraine divided into six groups based on their diagnosis: controls, PTSD, PTSD with TBI, TBI, complex PTSD (CPTSD), CPTSD with TBI. PTSD and CPTSD were diagnosed using the International Trauma Interview, and TBI using the Ohio State University TBI Identification Method. PACAP and BDNF levels were analyzed in the the fasting blood samples using ELISA. PACAP and BDNF levels in blood plasma in control group were 2.10 ± 0.26 and 5.13 ± 0.50 ng/ml, respectively. The study findings revealed no statistically significant differences in PACAP and BDNF levels among the study groups. The results obtained indicate potential limitations of using these biomarkers for stress disorders and TBI diagnosing in combat-exposed military populations and highlight the need for further research to identify reliable biomarkers with objective diagnostic value and prognostic significance.

Keywords: , , , ,


References:

  1. Stroth N, Holighaus Y, Ait-Ali D, Eiden LE. PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Ann N Y Acad Sci. 2011;1220(1):49-59. PubMed, PubMed, CrossRef
  2. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm SD, Kilaru V, Smith AK, Myers AJ, Ramirez M, Engel A, Hammack SE, Toufexis D, Braas KM, Binder EB, May V. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. 2011;470(7335):492-497. PubMed, PubMed, CrossRef
  3. Mojtabavi H, Saghazadeh A, van den Heuvel L, Bucker J, Rezaei N. Peripheral blood levels of brain-derived neurotrophic factor in patients with post-traumatic stress disorder (PTSD): A systematic review and meta-analysis. PLoS One. 2020;15(11):e0241928. PubMed, PubMed, CrossRef
  4. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33. PubMed
  5. Roberts NP, Cloitre M, Bisson J, Brewin CR. (2019). International Trauma Interview (ITI) for ICD 11 PTSD and complex PTSD (Test Version 3.2) [Clinical interview protocol]. protocols.io. https://content.protocols.io/files/rnu7cht8f.pdf.
  6. Bachem R, Maercker A, Levin Y, Köhler K, Willmund G, Bohus M, Koglin S, Roepke S, Schoofs N, Priebe K, Wülfing F, Schmahl C, Stadtmann MP, Rau H, Augsburger M. Assessing complex PTSD and PTSD: validation of the German version of the International Trauma Interview (ITI). Eur J Psychotraumatol. 2024;15(1):2344364. PubMed, PubMed, CrossRef
  7. Bondjers K, Hyland P, Roberts NP, Bisson JI, Willebrand M, Arnberg FK. Validation of a clinician-administered diagnostic measure of ICD-11 PTSD and Complex PTSD: the International Trauma Interview in a Swedish sample. Eur J Psychotraumatol. 2019;10(1):1665617. PubMed, PubMed, CrossRef
  8. Gelezelyte O, Roberts NP, Kvedaraite M, Bisson JI, Brewin CR, Cloitre M, Kairyte A, Karatzias T, Shevlin M, Kazlauskas E. Validation of the International Trauma Interview (ITI) for the Clinical Assessment of ICD-11 Posttraumatic Stress Disorder (PTSD) and Complex PTSD (CPTSD) in a Lithuanian Sample. Eur J Psychotraumatol. 2022;13(1):2037905. PubMed, PubMed, CrossRef
  9. Corrigan JD, Bogner J. Ohio State University Traumatic Brain Injury Identification Method. In: Kreutzer JS, DeLuca J, Caplan B. (eds.) Encyclopedia of Clinical Neuropsychology. Springer, Cham., 2018:2502-2504. CrossRef
  10. Dell’Oste V, Palego L, Betti L, Fantasia S, Gravina D, Bordacchini A, Pedrinelli V, Giannaccini G, Carmassi C. Plasma and Platelet Brain-Derived Neurotrophic Factor (BDNF) Levels in Bipolar Disorder Patients with Post-Traumatic Stress Disorder (PTSD) or in a Major Depressive Episode Compared to Healthy Controls. Int J Mol Sci. 2024;25(6):3529. PubMed, PubMed, CrossRef
  11. Bukovics P, Czeiter E, Amrein K, Kovacs N, Pal J, Tamas A, Bagoly T, Helyes Z, Buki A, Reglodi D. Changes of PACAP level in cerebrospinal fluid and plasma of patients with severe traumatic brain injury. Peptides. 2014;60:18-22. PubMed, CrossRef
  12. Pham D, Polgar B, Toth T, Jungling A, Kovacs N, Balas I, Pal E, Szabo D, Fulop BD, Reglodi D, Szanto Z, Herczeg R, Gyenesei A, Tamas A. Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson’s disease focusing on correlations with motor symptoms. Geroscience. 2022;44(2):785-803. PubMed, PubMed, CrossRef
  13. Domitrovic Spudic S, Nikolac Perkovic M, Uzun S, Nedic Erjavec G, Kozumplik O, Svob Strac D, Mimica N, Pivac N. Reduced plasma BDNF concentration and cognitive decline in veterans with PTSD. Psychiatry Res. 2022;316:114772. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.